Study of 90Y-hLL2 to Treat Non-Hodgkin's Lymphoma

Stopped early · Phase 1

Conditions studied: Non-Hodgkins Lymphoma

In brief

The purpose of this trial is to determine the safety of 90Y-hLL2 at different dose levels in the treatment of Non-Hodgkin's lymphoma.

Key facts

Study ID

NCT00054834

Run by

Gilead Sciences

People needed

27

Starts

2003-03-01

Last updated by the study team

2021-08-16

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Fox Chase Cancer Center — Philadelphia, Pennsylvania, United States
• MD Anderson Cancer Center — Houston, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.